SCOPUS 정보 검색 플랫폼

Value in Health

Volumn 4, Issue 3, 2001, Pages 225-250

Health economic guidelines - Similarities, differences and some implications

(3) Hjelmgren, Jonas a Berggren, Fredrik a,b Andersson, Fredrik a

a ASTRAZENECA R AND D (Sweden)

b LUND UNIVERSITY (Sweden)

Author keywords

Cost effectiveness; Economic evaluations; Health economic guidelines; Reimbursement

Indexed keywords

ARTICLE; AUSTRALIA; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; EUROPE; HEALTH ECONOMICS; METHODOLOGY; NORTH AMERICA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REIMBURSEMENT;

EID: 0034945594 PISSN: 10983015 EISSN: None Source Type: Journal
DOI: 10.1046/j.1524-4733.2001.43040.x Document Type: Article

Times cited : (288)

References (46)

1
- 0004109739
- Canberra: Government Publication
- (1992) Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee

2
- 0003995101
- Canberra: Commonwealth Department
- (1995) Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee

3
- 0003805392
- Toronto: Ontario Ministry of Health
- (1994) Ontario Guidelines for Economic Analysis of Pharmaceutical Products

4
- 0004000743
- Helsinki: Finish Ministry of Social Affairs and Health
- (1999) Guidelines for Reparation of an Account of Health Economic Aspects

5
- 0003930138
- Amstelveen: Health Insurance Council (Ziekenfondraad)
- (1999) Dutch Guidelines for Pharmacoeconomic Research

6
- 0004633967
- Lisbon: INFARMED
- (1998) Methodological Guidelines for Economic Evaluation Studies on Drugs

7
- 0003772280
- Seattle, WA: Regence Washington Health - University of Washington
- (1997) Guidelines for the Submission of Clinical and Economic Data Supporting Formulary Consideration (Version 1.2)

8
- 0033064813
- Incorporating clinical outcomes into drug formulary decisions: A practical approach
- (1999) Am J Managed Care , vol.5 , pp. 277-285
- Mather, D.B.¹ Sullivan, S.D.² Augenstein, D.³

9
- 0030056579
- Guidelines for authors and peer reviewers of economic submissions to the BMJ
- (1996) BMJ , vol.313 , pp. 275-283
- Drummond, M.F.¹ Jefferson, T.O.²

10
- 0004601038
- London: National Institute for Clinical Excellence
- (2001) Revised Guidelines for Manufacturers, Sponsors of Technologies Making Submissions to the Institute

11
- 0442291859
- Copenhagen: Schultz
- (1995) Economic evaluations of pharmaceuticals (in Danish: Sundhedskonomiske evalueringer af lægemidler)
- Alban, A.¹ Gyldemark, M.² Pedersen, A.V.³

12
- 0004636232
- Dublin: National Center for Pharmacoeconomics in Ireland
- (1999) Irish Healthcare Technology Assessment Guidelines (Draft Version 2)

13
- 0038757714
- Wellington, NZ: The Pharmaceutical Management Agency Limited (PHARMAC)
- (1999) A Prescription for Pharmacoeconomic Analysis (Version 1)

14
- 0004063769
- Oslo: Norwegian Medicines Control Authority Department of Pharmacoeconomics
- (1999) The Norwegian Guidelines for Pharmacoeconomic Analysis in Connection with Application for Reimbursement

15
- 0032855184
- Formulary guidelines for Blue Cross and Blue Shield of Colorado and Nevada
- (1999) PharmacoEconomics , vol.16 , pp. 211-224
- Langley, P.C.¹

16
- 0003520635
- Washington, DC: Food and Drug Administration (FDA)
- (1995) Principles for Review of Pharmacoeconomic Promotion (draft)

17
- 0003796307
- Alexandria, VA. Academy of Managed Care Pharmacy (AMCP)
- (2000) AMCP's Format for Formulary Submissions: A Format for Submissions of Clinical and Economic Evaluation Data in Support of Formulary Consideration by Managed Health Care Systems in the United States
- Gricar, J.A.¹ Langley, P.C.² Luce, B.³

18
- 0013566998
- Bern: Bundesamt für Sozíalversicherung
- (1995) Swiss Manual for the Standardization of Clinical and Economic Evaluation of Medical Technology (second draft)

19
- 0003711668
- Brussels: Belgian Society for Pharmacoepidemiology (BESPE)
- (1995) A Proposal for Methodological Guidelines for Economic Evaluation of Pharmaceuticals

20
- 0003866632
- Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA)
- (1997) Guidelines for Economic Evaluation of Pharmaceuticals (2nd edn.)

21
- 0003401898
- Paris: Collège des Economistes de la Santé (CES)
- (1997) Guidelines and Recommendations for French Pharmacoeconomic Studies

22
- 0028860056
- A proposal for Italian guidelines in pharmacoeconomics
- (1995) PharmacoEconomics , vol.7 , pp. 1-6
- Garattini, L.¹ Grilli, R.² Scopelliti, D.³ Mantovani, L.⁴

23
- 0013550906
- Madrid: General Directorate of Services and Evaluation of Health Technologies and the General Directorate of Insurance and Health Planning of the Ministry of Health and Consumption
- (1994) Proposal for Standardization of Some Methodological Aspects of Cost-Effectiveness Analyses (CEA), Cost-Utility Analyses (CUA), and Cost-Minimization Analyses (CMA) in the Evaluating of Health Technologies and Programs

24
- 0029096271
- Economic analysis of health technologies and programs. A Spanish proposal for methodological standardization
- (1995) PharmacoEconomics , vol.8 , pp. 245-252
- Rovira, J.¹ Antonanzas, F.²

25
- 0028942553
- Hanover Guidelines für die ökonomische evaluation von gesundheitsgütern und -dienstleistungen
- Hanover: Institut für Versicherungsbetriebslehre, Diskussionspapier Nr. 10, January 1995
- (1995) Die Pharmazeutische Industrie , vol.57 , pp. 265-268
- Graf vd Shulenberg, J.-M.¹

26
- 0028649473
- UK guidance on good practice in the conduct of economic evaluations of medicines
- (1994) Br J Med Ec , vol.7 , pp. 63-64

27
- 0031017983
- Guidelines for pharmacoeconomic studies. Recommendations from the Panel on Cost-effectiveness in Health and Medicine
- (1997) PharmacoEconomics , vol.11 , pp. 159-168
- Siegel, J.E.¹ Torrance, G.W.² Russell, L.B.³

28
- 0004090711
- Washington, DC: Pharmaceutical Research and Manufacturers of America (PhRMA)
- (1995) Methodological and Conduct Principles for Pharmacoeconomic Research

29
- 0029063563
- Economic analysis of health care technology. A report on principles
- (1995) Ann Intern Med , vol.122 , pp. 61-70

30
- 0028686315
- Guidelines for pharmacoeconomic studies - The ways forward
- (1994) PharmacoEconomics , vol.6 , pp. 493-497
- Drummond, M.F.¹

31
- 0003469046
- New York: Oxford University Press
- (1996) Cost-Effectiveness in Health and Medicine
- Gold, R.G.¹ Russell, L.R.² Siegel, J.E.³

32
- 0003458828
- Oxford: Oxford University Press
- (1997) Methods for the Economic Evaluation of Health Care Programmes (2nd edn.)
- Drummond, M.F.¹ O'Brien, B.² Stoddart, L.G.³

33
- 0028944255
- Methods of cost-effectiveness analysis: Areas of consensus and debate
- (1995) Clin Ther , vol.17 , pp. 109-125
- Luce, B.R.¹ Simpson, K.²

34
- 0004589797
- Cost-effectiveness evaluation in health care: Initiative for a standardized methodology
- (1995) Managed Care Med , vol.2 , pp. 25-33
- DeVries, A.¹ Gagnon, J.P.²

35
- 0028991776
- A comparative review of pharmacoeconomic guidelines
- (1995) PharmacoEconomics , vol.8 , pp. 182-189
- Jacobs, P.¹ Bachynsky, J.² Baladi, J.-F.³

36
- 0029830348
- Review of health economic guidelines in the form of regulations, principles, policies and positions
- (1996) Drug Information Journal , vol.30 , pp. 1003-1016
- Genduso, A.G.¹ Kotsanos, J.K.²

37
- 0032431094
- Emerging standardization in pharmacoeconomics
- (1998) Clin Ther , vol.20 , pp. 1194-1202
- Mullins, D.C.¹ Ogilvie, S.²

38
- 0001245197
- Current trends in the use of pharmacoeconomics and outcomes research in Europe
- (1999) Value Health , vol.2 , pp. 323-332
- Drummond, M.¹ Dubois, D.² Garattini, L.³

39
- 0034114699
- A NICE Challenge for health economics
- (2000) Health Econ , vol.9 , pp. 89-93
- Hutton, J.¹ Maynard, A.²

40
- 0034716729
- Problems with the interpretation of pharmacoeconomic analyses - A review of submissions to the Australian Pharmaceutical Benefit Scheme
- (2000) JAMA , vol.283 , pp. 2116-2121
- Hill, S.R.¹ Mitchell, A.S.² Henry, D.A.³

41
- 0033912957
- Using economic evaluation to make formulary coverage decisions - So much for guidelines
- (2000) PharmacoEconomics , vol.18 , pp. 55-62
- Anis, A.H.¹ Gagnon, Y.²

42
- 0034716730
- Pharmacoeconomic analyses-making them transparent, making them credible
- (2000) JAMA , vol.283 , pp. 2158-2160
- Rennie, D.¹ Luft, H.S.²

43
- 0004597702
- NICE rejects Glaxo Wellcome appeal against Relenza NHS ban
- (1999) Pharmaceut J , vol.263 , pp. 56

44
- 34548517264
- A nasty start for NICE
- (1999) Lancet , vol.354 , Issue.9187 , pp. 1313

45
- 85031510766
- Toronto Globe and Mail, November 17
- (1999) Drug firm threatens suit over MD's product review
- Schuchman, M.¹

46
- 85031513948
- Sydney Morning Herald, December 1
- (1999) Cut-price medicine put at risk
- Wilkingson, M.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.